Skip to main content
. 2017 Apr;22(2):146–155. doi: 10.17712/nsj.2017.2.20170093

Table 1.

Critical appraisal of the Source CPGs by the Appraisal of Guidelines for Research & Evaluation II (AGREE II) Instrument.

CPGs AGREE-II domains scores (%) Texas 2009 NICE 2012 NCS 2012 AES 2016
Domain 1: Scope & Purpose 92 100 78 100
Domain 2: Stakeholder Involvement 47 100 41 44
Domain 3: Rigour of Development 56 98 68 69
Domain 4: Clarity & Presentation 100 97 80 92
Domain 5: Applicability 48 85 10 21
Domain 6: Editorial Independence 50 88 19 38
Overall Assessment (%) 85 100 57 75
Recommendation for CPG use Yes - 1, Yes with modifications - 1, No - 0 Yes - 1, Yes with modifications - 1, No - 0 Yes - 1, Yes with modifications - 0, No - 1 Yes - 1, Yes with modifications - 1, No - 0

The overall assessment and decision of the CPG Adaptation working group, based on the AGREE-II domain scores, was to adapt the NICE CPG and exclude the Texas, NCS, and AES CPGs. CPGs: Clinical Practice Guidelines, AGREE: Appraisal of Guidelines for Research and Evaluation, Texas: Texas Children’s Hospital Evidence-Based Outcomes Center, NICE: National Institute for Health and Care Excellence, NCS: Neurocritical Care Society, AES: American Epilepsy Society